Celcuity Inc. (CELC)
NASDAQ: CELC · IEX Real-Time Price · USD
16.19
-0.45 (-2.70%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Celcuity Market Cap
Celcuity has a market cap or net worth of $568.29 million as of July 2, 2024. Its market cap has increased by 112.44% in one year.
Market Cap
568.29M
Enterprise Value
428.55M
1-Year Change
112.44%
Ranking
Category
Stock Price
$16.19
Market Cap Chart
Since September 20, 2017, Celcuity's market cap has increased from $133.90M to $568.29M, an increase of 324.41%. That is a compound annual growth rate of 23.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 505.60M | 43.39% |
| Dec 29, 2023 | 352.60M | 62.79% |
| Dec 30, 2022 | 216.60M | 10.12% |
| Dec 31, 2021 | 196.70M | 108.59% |
| Dec 31, 2020 | 94.30M | -13.57% |
| Dec 31, 2019 | 109.10M | -55.23% |
| Dec 31, 2018 | 243.70M | 27.52% |
| Dec 29, 2017 | 191.10M | 42.72% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cassava Sciences | 592.51M |
| Fulgent Genetics | 587.11M |
| Arbutus Biopharma | 583.14M |
| Mineralys Therapeutics | 580.89M |
| REGENXBIO | 576.30M |
| Humacyte | 571.60M |
| Paragon 28 | 567.39M |
| Pharming Group | 562.32M |